PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.02%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
-3.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-3.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.06%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.75%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-0.53%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-1.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.09%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
38.46%
OCF growth above 1.5x ADI's 5.63%. David Dodd would confirm a clear edge in underlying cash generation.
1040.43%
FCF growth above 1.5x ADI's 2.59%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.63%
10Y revenue/share CAGR under 50% of ADI's 182.11%. Michael Burry would suspect a lasting competitive disadvantage.
13.51%
5Y revenue/share CAGR under 50% of ADI's 45.27%. Michael Burry would suspect a significant competitive gap or product weakness.
19.91%
3Y revenue/share CAGR under 50% of ADI's 55.83%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
103.13%
10Y OCF/share CAGR under 50% of ADI's 221.00%. Michael Burry would worry about a persistent underperformance in cash creation.
-1.85%
Negative 5Y OCF/share CAGR while ADI is at 36.67%. Joel Greenblatt would question the firm’s operational model or cost structure.
35.56%
3Y OCF/share CAGR at 50-75% of ADI's 51.22%. Martin Whitman would suspect weaker recent execution or product competitiveness.
227.96%
Similar net income/share CAGR to ADI's 207.64%. Walter Schloss would see parallel tailwinds or expansions for both firms.
16.17%
Below 50% of ADI's 57.14%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
27.56%
Below 50% of ADI's 78.36%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
81.65%
Below 50% of ADI's 378.03%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
68.77%
Below 50% of ADI's 145.59%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
101.75%
3Y equity/share CAGR at 75-90% of ADI's 124.84%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
341.28%
10Y dividend/share CAGR above 1.5x ADI's 153.63%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
99.61%
5Y dividend/share CAGR 1.25-1.5x ADI's 78.69%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
37.84%
3Y dividend/share CAGR similar to ADI's 38.76%. Walter Schloss finds parallel short-term dividend strategies for both companies.
1.02%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.80%
Inventory growth well above ADI's 3.71%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.26%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.34%
BV/share growth above 1.5x ADI's 0.63%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.03%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-1.26%
Our R&D shrinks while ADI invests at 1.92%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.95%
We cut SG&A while ADI invests at 3.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.